Methohexital
Barbiturate — NERVOUS SYSTEM
Also known as: brevital sodium, enallynymall, methodrexitone, methohexital sodium, methohexitone, metoesital
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Methohexital is an ofp drug in the Barbiturate class catalogued in DrugCentral. It was first approved by the FDA in 1960. DrugCentral lists 3 molecular targets, including GLRA1, GABRA1|GABRG2|GABRB3 and CHRNB2|CHRNA2. Recorded indications include General anesthesia and Local anesthesia.
- Approval status: ofp (first approved 1960 by the FDA).
- Drug class: Barbiturate.
- Molecular targets: GLRA1, GABRA1|GABRG2|GABRB3 and CHRNB2|CHRNA2 (3 listed in DrugCentral).
- Indications: General anesthesia and Local anesthesia.
- ATC code: N01AF01 (Barbiturates, plain).
- Molecular formula: C14H18N2O3; molecular weight 262.31 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (2)
- General anesthesia
- Local anesthesia
Contraindications (12)
- Anemia
- Asthma
- Chronic heart failure
- Chronic obstructive lung disease
- Hepatic failure
- Hypertensive urgency
- Kidney disease
- Low blood pressure
- Morbid obesity
- Porphyria
- Seizure disorder
- Shock
Mechanism & targets
| Established pharmacologic class | Barbiturate |
|---|
Molecular targets (3)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Glycine receptor subunit alpha-1 | GLRA1 | unknown | — |
| GABA-A receptor alpha-1/beta-3/gamma-2 | GABRA1|GABRG2|GABRB3 | positive allosteric modulator | — |
| Neuronal acetylcholine receptor; alpha2/beta2 | CHRNB2|CHRNA2 | unknown | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1960-06-27 | FDA | — | PAR STERILE PRODUCTS |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N01AF01 | NERVOUS SYSTEM › ANESTHETICS › ANESTHETICS, GENERAL › Barbiturates, plain |
N05CA15 | NERVOUS SYSTEM › PSYCHOLEPTICS › HYPNOTICS AND SEDATIVES › Barbiturates, plain |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Methohexital is on its molecule page.
| Molecular formula | C14H18N2O3 |
|---|---|
| Molecular weight | 262.31 g/mol |
| CAS number | 151-83-7 |
| InChIKey | NZXKDOXHBHYTKP-UHFFFAOYSA-N |
| PubChem CID | 9034 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Methohexital used for?
DrugCentral lists the following indications for Methohexital: General anesthesia and Local anesthesia.
How does Methohexital work?
Its molecular targets in DrugCentral include GLRA1, GABRA1|GABRG2|GABRB3 (positive allosteric modulator) and CHRNB2|CHRNA2.
When was Methohexital first approved?
Methohexital was first approved by the FDA in 1960.
What drug class does Methohexital belong to?
Methohexital is in the Barbiturate class.
What is the chemical formula of Methohexital?
Methohexital has the molecular formula C14H18N2O3 and a molecular weight of 262.31 g/mol.
Browse: all drugs starting with M · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1748 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL30219 — compound record and bioactivity
- PubChem CID 9034 — chemical identifiers
- DrugBank DB00474 — drug record
- FDA UNII E5B8ND5IPE — substance identity
- DailyMed: FDA labels for Methohexital — current prescribing information (label search)
- UniProt P23415 (GLRA1) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.